Stacy Lindborg - Aug 4, 2025 Form 4 Insider Report for Imunon, Inc. (IMNN)

Role: President and CEO, Director
Signature: /s/ Susan Eylward, Attorney-in-Fact for Stacy Lindborg
Stock symbol: IMNN
Transactions as of: Aug 4, 2025
Transactions value $: $0
Form type: 4
Date filed: 8/6/2025, 04:21 PM
Previous filing: Mar 18, 2025
Next filing: Sep 9, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Lindborg Stacy	President and CEO, Director	C/O IMUNON, INC., 997 LENOX DRIVE, SUITE 100, LAWRENCEVILLE	/s/ Susan Eylward, Attorney-in-Fact for Stacy Lindborg	2025-08-06	0001813667

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMNN	Stock Option (Right to Buy)	Award	$0	+5K		$0.00	5K	Aug 4, 2025	Common Stock	5K	$9.20	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the closing price of Imunon, Inc. Common Stock on the date of the grant
F2	The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

Remarks:

On July 25, 2025, the Issuer effected a reverse stock split of Issuer Common Stock at a ratio of 1-for-15 (the "Reverse Stock Split"). As a result of the Reverse Stock Split, the shares of Issuer Common Stock, and the exercise price and shares of Issuer Common Stock underlying outstanding equity awards, have been adjusted accordingly versus any amounts previously reported by the Reporting Person.